|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | PhaseⅢstudy comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women:The european organisation for research and treatment of cancer breast cancer cooperative group显示文摘 | Paridaens R J Dirix L Y Beex L V | 2008 | J Clin Oncol2008，26，30： | 1 |
| 2 | Phase Ⅲ study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer显示文摘 | MILES D W CHAN A DIRIX L Y | 2010 | J Clin Oncol2010，28，20： | 1 |
| 3 | Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer 显示文摘 | Miles D W Chan A Dirix L Y | 2010 | J Clin Oncol2010，28，20： | 1 |
| 4 | Nerainib,an irreversible Erb B receptor tyrosine kinase inhibitor,in patients with advanced Erb B2-positive breast cancer显示文摘 | Burstein H J Sun Y Dirix L Y | 2010 | J Clin Oncol2010，28，8： | 1 |
| 5 | Angiogene-sis,lymphangiogenesis,growth pattern,and tumor emboli in in-flammatory breast cancer:a review of the current knowledge显示文摘 | Vermeulen P B van Golen K L Dirix L Y | | 0，，： | 1 |
| 6 | Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients显示文摘 | Dirix L Y Vermeulen P B Pawinski A | 1997 | British J Cancer1997，76，2： | 1 |
| 7 | Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients显示文摘 | VERMEULEN P B PAWINSKI A | 1997 | Br J Cancer1997，76，2： | 1 |
| 8 | Phase m study of bevacizumab plus docetaxel compared with placebo plus do- cetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer显示文摘 | MILES D W CHAN A DIRIX L Y | 2010 | J Clin Oncol2010，28，20： | 1 |
| 9 | Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer显示文摘 | BURSTEIN H J SUN Y DIRIX L Y | 2010 | J Clin Oncol2010，28，8： | 1 |
| 10 | The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review显示文摘 | Dirix L Y Van-Oosterom A T | 1990 | Semin Oncol1990，17，24： | 1 |
| 11 | Phase III study of bevaci- zumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor re- ceptor 2-negative metastatic breast cancer 显示文摘 | Miles D W Chan A Dirix L Y | 2010 | J Clin Oncol2010，28，20： | 1 |
| 12 | Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies 显示文摘 | Thertulien R Manikhas GM Dirix L Y | 2012 | Cancer Chemother Pharmacol2012，69，2： | 1 |
| 13 | Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival inpatients with metastatic breast cancer显示文摘 | Dirix L Y Salgado R Weytjens R | 2002 | Br J Cancer2002，86，3： | 1 |
| 14 | Exemestane is superior to megestrol acetate folloming tamoxifen failure in advanced breast cancer : results of a phase III randomized double-blind trial显示文摘 | Kaufmann M Bajetta E Dirix L Y | 2000 | J Clin Oncol2000，18，7： | 1 |
| 15 | Exemestane is superior to megestrol acetate after tamoxifen failure in post menopausal women with advanced breast cancer; result s of a phase Ⅲ randomised double-blind study 显示文摘 | Kaufmann M Bajetta E Dirix L Y | 2000 | Clin Oncol2000，，18： | 1 |
| 16 | Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge 显示文摘 | Verrneulen P B van Golen K L Dirix L Y | 2010 | Cancer2010，116，11： | 1 |
| 17 | Neratinib, an irre- versible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2 -positive breast cancer显示文摘 | BURSTEIN H J SUN Y DIRIX L Y | 2010 | J Clin Oncol2010，28，8： | 1 |
| 18 | Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer 显示文摘 | Dirix L Y Salgado R Weytjens R | 2002 | Br J Cancer2002，86，11： | 1 |
| 19 | Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer显示文摘 | Dirix L Y Vermeulen P B Hubens L | 1996 | Ann Oncol1996，7，3： | 1 |
| 20 | Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer 显示文摘 | Dirix L Y Salgado R Weytjens R | 2002 | Br J Cancer2002，86，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员